Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. (MRVI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRVI · as of Jun 8, 2026
Key Statistics
Explore Maravai LifeSciences Holdings, Inc. Data
mrvi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 50.0%
The MRVI analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $5.25, representing +4.58% upside from the current price of $5.02.
Competitors & Peers
mrvi competitorsMRVI
BCAX
DNA
IOVA
KURA
LENZStock Performance
Full HistoryAbout Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the …
what is maravai lifesciences holdings, inc. · mrvi stock overview · maravai lifesciences holdings, inc. company profile · who is maravai lifesciences holdings, inc. ceo · mrvi NASDAQ · maravai lifesciences holdings, inc. headquarters · maravai lifesciences holdings, inc. business segments
About Stock Overview & Key Data
Maravai LifeSciences Holdings, Inc. (MRVI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 20, 2020. As of the latest trading session, MRVI stock price is $5.02, with a market capitalization of $1.4B. The stock has returned +120.18% over the past 12 months and +54.46% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Maravai LifeSciences Holdings, Inc. stock is Buy, with an average 12-month price target of $5.25. In fiscal year 2025, Maravai LifeSciences Holdings, Inc. reported revenue of $185.7M and net income of -$130.8M. For detailed data — including Maravai LifeSciences Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Maravai LifeSciences Holdings, Inc. (MRVI) stock price is $5.02. The stock is traded on NASDAQ under the ticker symbol MRVI. The 52-week range is $1.99 – $5.13.